person · Reporting owner
Osterloh Albert Frederick IV
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DEXCOM INCDXCM · Entity 3114 | Director | May 28, 2026 | June 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DEXCOM INC
Report date May 28, 2026 · Filed June 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,691 |
Reported balance
After 2026-05-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 1,630 · Balance 8,691 F1: The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F2: Included in this number are 8,691 unvested restricted stock units, 1,630 of which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders, and 7,061 of which were granted on February 26, 2026 and shall vest through February 26, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2: Included in this number are 8,691 unvested restricted stock units, 1,630 of which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders, and 7,061 of which were granted on February 26, 2026 and shall vest through February 26, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2026 Filed Jun 1, 2026 21:34 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 1,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000120 · wk-form4_1780349682.xml · nonDerivative · entry 1 Osterloh Albert Frederick IV · CIK 0002111108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,691 F1 · shares: The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F2 · balance_after: Included in this number are 8,691 unvested restricted stock units, 1,630 of which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders, and 7,061 of which were granted on February 26, 2026 and shall vest through February 26, 2029. Read SEC document |
| February 26, 2026 Filed Feb 26, 2026 21:32 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 7,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000034 · wk-form4_1772141531.xml · nonDerivative · entry 1 Osterloh Albert Frederick IV · CIK 0002111108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,061 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.